“The Measurement of Risk Communication in the Breast Cancer Treatment Consultation”

December 8, 2011

9:00 a.m. - 10:00 a.m.

701 Blockley Hall

Marilyn Schapira, MD, PhD

Center for Clinical Epidemiology and Biostatistics

Target Audience

This program has been designed for medical practitioners in infectious diseases, diabetes, genomics, obstetrics and gynecology, nephrology, community health and prevention, oncology, critical care, pulmonary medicine, health care rationing, molecular genetics, cancer epidemiology, prevention and control.

Educational Objectives

After completing this activity, participants should be able to:

  • Discuss the application of epidemiologic approaches in settings other than one’s own clinical and/or research findings
  • Identify new approaches for research
  • Critically evaluate new research findings
  • Identify new data sources for epidemiologic studies
  • Present an aspect of research at a level appropriate for an audience knowledgeable about research in clinical epidemiology
  • Discuss methodology in adequate detail so that the audience can consider how research apply to their own medical specialty
  • Present and encourage discussion of problems and potential solutions that have come up in research so that the audience can learn from experience and/or contribute to advancing their own research

Accreditation

The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support*

NONE

For more information, please contact

Cathy Mulvaney/Karen Murphy

215-573-4866 / 215-573-5568

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania andthe peer reviewer(s) Zalman Agus, MD, Associate Dean for CME, have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Faculty Name

Arwin Thomasson / Jinbo Chen, PhD / Marcella Devoto, PhD / Scott Halpern, MD, PhD, MBE
Hongzhe Li, PhD / Mary Putt, PhD, ScH / Kathryn Schmitz, PhD, MPH / Douglas Wiebe, PhD
Marilyn Marilyn Schapira, MD, MPHMPH HMPH / MIngyao, Li, PhD

Presenter Name

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.

Faculty NameName of Commercial InterestRelationship

Robert Gross, MDAbbott LaboratoriesResearch Grant

Ebbing Lautenbach, MD, MPH, MSCEAmerican College of PhysiciansEditorial Board Member

Informa Healthcare / U of Chicago / U of MichiganRoyalties/Editorial Board member

Steven Kawut, MD, MSGileadConsultant, Clinical Trial, Grant Reviewer

PfizerGrant Reviewer, Consultant

Merck & IkaraConsultant

ActelionResearch

David Margolis, MD, PhDAbbott, BMS, J&J Centocor, PfizerDSMB

AstellasGrant Reviewer

Wound Solutions, Trident, ServierConsultant

Mary Putt, Ph.D.American Society of GastroenterologyEditorial Board Member

National Institute of HealthGrant Reviewer

Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

Disclosure of Unapproved Uses of Products

Presenter nameProductInvestigational and/or Off-label Use